Press Release: Research Solutions Reports Fourth Quarter and Fiscal Year 2025 Results

Dow Jones
Sep 19, 2025

Reports 36% YoY Platform Revenue Increase, ARR of $20.9 Million and Record Fiscal Year Net Income and Adjusted EBITDA

HENDERSON, Nev., Sept. 18, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research workflow platform, reported financial results for its fourth quarter and full fiscal year ended June 30, 2025.

Fiscal Fourth Quarter 2025 Summary (compared to prior-year quarter)

   -- Platform revenue up 21% to $5.2 million. Annual Recurring Revenue ("ARR") 
      up 20% to $20.9 million, which includes approximately $14.2 million of 
      B2B recurring revenue and $6.7 million of B2C recurring revenue. 
 
   -- Total revenue of $12.4 million, a 3% increase. 
 
   -- Gross profit up 12%. Total gross margin improved 450 basis points to 51%, 
      crossing 50% on a blended basis for the first time in the Company's 
      history. 
 
   -- Net income of $2.4 million, or $0.07 per diluted share, compared to net 
      loss of $2.8 million or ($0.09) per share. This quarter's result includes 
      a $1.1 million favorable adjustment related to the final earnout 
      adjustment for Scite.  Last year's result included a negative adjustment 
      charge in other expense of approximately $4.3 million related to the 
      projected earnout for Scite. 
 
   -- Adjusted EBITDA increased 15% to a Company record of $1.6 million. 
 
   -- Cash flow from operations of $2.3 million, compared to $2.0 million. 

Fiscal Year 2025 Summary (compared to Fiscal 2024)

   -- Platform revenue up 36% to $19.0 million. 
 
   -- Total revenue of $49.1 million, a 10% increase. 
 
   -- Gross profit up 23%. Total gross margin improved 530 basis points to 
      49.3%. 
 
   -- Net income of $1.3 million, or $0.04 per diluted share, compared to a net 
      loss of $3.8 million, or ($0.13) per share.  This year's result includes 
      $1.7 million of net other expense related to the Scite earn-out compared 
      to $5.1 million of net other expense related to the Scite earnout in 
      fiscal 2024. 
 
   -- Adjusted EBITDA of $5.3 million, a Company record, compared to $2.2 
      million. 
 
   -- Cash flow from operations of $7.0 million, a Company record, compared to 
      $3.6 million.  The Company ended the fiscal year with $12.2 million in 
      cash and cash equivalents. 

"Fiscal 2025 reflects a year of significant progress in our ongoing SaaS software and AI solution set transition, with our platform revenue now representing nearly 40% of total revenue for the year compared to 31% in fiscal 2024. As expected, this strategic shift and continued focus on recurring revenue has also translated into meaningful increases in gross margin, Adjusted EBITDA and operating cash flow," said Roy W. Olivier, President and CEO of Research Solutions. "Following the final earnout calculation for Scite, we proactively adjusted the payout structure, offering more cash and reducing dilution to current shareholders. We remain focused on improving on our 'Rule of 40' goal, with a slight bias towards increased growth versus profitability, which in turn should create long-term value for our shareholders. In addition, we used the Scite acquisition to help build out the AI capabilities in our product set and we continue to actively pursue additional opportunities that enhance, complement and strengthen our current product offerings. The growth rate of our AI-based Scite product is over 40%, which I view as a good indication that we are on the right track. Lastly, from a cash and Adjusted EBITDA perspective, we are better positioned than we ever have been to execute on these opportunities."

Fiscal Fourth Quarter 2025 Results

Total revenue was $12.4 million, compared to $12.1 million in the year-ago quarter driven by increased platform revenue versus the prior-year period.

Platform subscription revenue for the quarter was $5.2 million, a 21% year-over-year increase from the prior-year period. The increase was due to organic growth in the core B2C and B2B platforms, with the latter increasing due to a mix of new logo generation and upsell and cross sell into existing customers. The quarter ended with annual recurring revenue of $20.9 million, up 20% year-over-year (see the Company's definition of annual recurring revenue below).

Transaction revenue was $7.3 million, compared to $7.9 million in the fourth quarter of fiscal 2024. The decrease was due to lower paid order volume. The transaction active customer count for the quarter was 1,338, compared to 1,398 customers in the prior-year quarter (see the Company's definition of active customer accounts and transactions below).

Total gross margin improved 450 basis points from the prior-year quarter to 51.0%. The increase was primarily driven by the continued revenue mix shift to the higher-margin Platforms business, including the expansion of the gross margin for that business.

Total operating expenses were $5.1 million, compared to $5.0 million in the fourth quarter of 2024. The increase was primarily related to higher sales and marketing expenses offset by reduced stock compensation expense.

Other income for the quarter was approximately $1.2 million compared to other expense of approximately $3.5 million in the fourth quarter of fiscal 2024. This quarter's result includes a $1.1 million favorable adjustment related to the final determination of the Scite earnout. Last year's result included a negative adjustment in other expense of approximately $4.3 million related to the projected earnout for Scite.

Net income in the fourth quarter was $2.4 million, or $0.07 per diluted share, compared to net loss of $2.8 million, or ($0.09) per share, in the prior-year quarter. Adjusted EBITDA was $1.6 million, compared to $1.4 million in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

Full-Year Fiscal 2025 Results

Total revenue was $49.1 million, a 10% increase from fiscal 2024, driven by increased platform revenue.

Platform subscription revenue for fiscal 2025 was $19.0 million, a 36% year-over-year increase. The increase was primarily due to organic growth in the core B2C and B2B platforms, including 150 net new B2B platform deployments, as well as having a full fiscal year of Scite revenue (versus seven months in fiscal 2024).

Transaction revenue was $30.1 million, compared to $30.7 million in fiscal 2024. The decrease was due to lower paid order volume in the second half of fiscal 2025.

Total gross margin improved 530 basis points from the prior-year to 49.3%. The increase was primarily driven by the continued revenue mix shift to the higher-margin Platforms business.

Total operating expenses for the year were $21.7 million, compared to $20.4 million in fiscal 2024. The increase was primarily related to higher sales and marketing expenses offset by reduced general and administrative and stock compensation expenses.

Net income for fiscal 2025 was $1.3 million, or $0.04 per diluted share, compared to net loss of $3.8 million, or ($0.13) per share, in the prior year. Adjusted EBITDA was $5.3 million, compared to $2.2 million in fiscal 2024 (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

Conference Call

Research Solutions President and CEO Roy W. Olivier and CFO Bill Nurthen will host the conference call, followed by a question and answer period.

Date: Thursday, September 18, 2025

Time: 5:00 p.m. ET (2:00 p.m. PT)

Dial-in number: 1-203-518-9783

Conference ID: RESEARCH

The conference call will be broadcast live and available for replay until October 18, 2025 by dialing 1-412-317-6671 and using the replay ID 11159860, and via the investor relations section of the Company's website at http://researchsolutions.investorroom.com/.

Fiscal Fourth Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter

 
                                              Quarter Ended June 30,                                           Twelve Months Ended June 30, 
                               2025              2024              Change        % Change         2025               2024               Change        % Change 
                         ----------------  ----------------  ------------------  ---------  ----------------  ------------------  -----------------  --------- 
Revenue: 
 Platforms                 $    5,184,864    $    4,277,338      $      907,526     21.2 %     $  18,955,695       $  13,956,517      $   4,999,178     35.8 % 
 Transactions              $    7,253,053    $    7,856,176           (603,123)     -7.7 %     $  30,102,286       $  30,667,382          (565,096)     -1.8 % 
                         ----------------  ----------------  ------------------  ---------  ----------------  ------------------  -----------------  --------- 
Total Revenue                  12,437,917        12,133,514             304,403      2.5 %        49,057,981          44,623,899          4,434,082      9.9 % 
 
Gross Profit: 
 Platforms                      4,590,639         3,650,286             940,353     25.8 %        16,584,155          11,889,314          4,694,841     39.5 % 
 Transactions                   1,751,263         1,992,580           (241,317)    -12.1 %         7,611,796           7,750,852          (139,056)     -1.8 % 
                         ----------------  ----------------  ------------------  ---------  ----------------  ------------------  -----------------  --------- 
Total Gross Profit              6,341,902         5,642,866             699,036     12.4 %        24,195,951          19,640,166          4,555,785     23.2 % 
 
Gross profit as a % of 
revenue: 
 Platforms                         88.5 %            85.3 %               3.2 %                       87.5 %              85.2 %              2.3 % 
 Transactions                      24.1 %            25.4 %              -1.2 %                       25.3 %              25.3 %              0.0 % 
Total Gross Profit                 51.0 %            46.5 %               4.5 %                       49.3 %              44.0 %              5.3 % 
 
Operating Expenses: 
 Sales and marketing            1,219,184           830,195             388,989     46.9 %         5,360,356           3,442,503          1,917,853     55.7 % 
 Technology and product 
  development                   1,356,801         1,489,491           (132,690)     -8.9 %         5,631,344           5,442,382            188,962      3.5 % 
 General and 
  administrative                2,152,855         1,917,907             234,948     12.3 %         7,936,644           8,511,697          (575,053)     -6.8 % 
 Depreciation and 
  amortization                    315,021           311,004               4,017      1.3 %         1,245,362             836,271            409,091     48.9 % 
 Stock-based 
  compensation                    176,611           426,190           (249,579)    -58.6 %         1,723,561           2,155,461          (431,900)    -20.0 % 
 Foreign currency 
  translation loss 
  (gain)                         (83,322)             6,336            (89,658)         NM         (202,527)              21,395          (223,922)         NM 
Total Operating 
 Expenses                       5,137,150         4,981,123             156,027      3.1 %        21,694,740          20,409,709          1,285,031      6.3 % 
                         ----------------  ----------------  ------------------  ---------  ----------------  ------------------  -----------------  --------- 
Income (loss) from 
 operations                     1,204,752           661,743             543,009     82.1 %         2,501,211           (769,543)          3,270,754         NM 
 
Other Income 
(Expenses): 
 Other income 
  (expenses)                    1,163,557       (3,451,948)           4,615,505         NM       (1,152,847)         (2,903,983)          1,751,136         NM 
 Provision for income 
  taxes                           (7,995)          (31,022)              23,027    -74.2 %          (82,811)           (113,071)             30,260    -26.8 % 
                                                             ------------------  ---------  ----------------                      -----------------  --------- 
Total Other Income 
 (Expenses):                    1,155,562       (3,482,970)           4,638,532         NM       (1,235,658)         (3,017,054)          1,781,396         NM 
                         ----------------  ----------------  ------------------  ---------  ----------------  ------------------  -----------------  --------- 
Net income (loss)          $    2,360,314    $  (2,821,227)           5,181,541         NM    $    1,265,553      $  (3,786,597)          5,052,150         NM 
                         ================  ================  ==================  =========  ================  ==================  =================  ========= 
                                                                                                                                                            NM 
Adjusted EBITDA            $    1,613,062    $    1,405,273      $      207,789     14.8 %    $    5,267,607      $    2,243,584      $   3,024,023    134.8 % 
 
                                              Quarter Ended June 30,                                           Twelve Months Ended June 30, 
                               2025              2024              Change         % Change        2025               2024               Change        % Change 
                         ----------------  ----------------  ------------------  ---------  ----------------  ------------------  -----------------  --------- 
 Platforms: 
 B2B ARR (Annual 
 recurring revenue*): 
  Beginning of Period       $  13,474,074     $  11,653,062       $   1,821,012     15.6 %     $  12,060,201      $    9,444,129      $   2,616,072     27.7 % 
   Incremental ARR                723,524           407,139             316,385     77.7 %         2,137,397           2,616,072          (478,675)    -18.3 % 
                         ----------------  ----------------  ------------------  ---------  ----------------  ------------------  -----------------  --------- 
  End of Period             $  14,197,598     $  12,060,201       $   2,137,397     17.7 %     $  14,197,598       $  12,060,201      $   2,137,397     17.7 % 
 
 Deployments: 
  Beginning of Period               1,133               983                 150     15.3 %             1,021                 835                186     22.3 % 
   Incremental 
    Deployments                        38                38                   -      0.0 %               150                 186               (36)    -19.4 % 
                         ----------------  ----------------  ------------------  ---------  ----------------  ------------------  -----------------  --------- 
  End of Period                     1,171             1,021                 150     14.7 %             1,171               1,021                150     14.7 % 
 
 ASP (Average sales 
 price): 
  Beginning of Period    $         11,892  $         11,855  $               38      0.3 %  $         11,812    $         11,310  $             502      4.4 % 
  End of Period          $         12,124  $         11,812   $             312      2.6 %  $         12,124    $         11,812  $             312      2.6 % 
 
 B2C ARR (Annual 
 recurring revenue*): 
  Beginning of Period      $    6,877,926    $    4,902,975       $   1,974,951         NM    $    5,363,129  $                -      $   5,363,129         NM 
   Incremental ARR              (156,570)           460,154           (616,724)         NM         1,358,227           5,363,129        (4,004,902)         NM 
                         ----------------  ----------------  ------------------  ---------  ----------------  ------------------  -----------------  --------- 
  End of Period            $    6,721,356    $    5,363,129       $   1,358,227     25.3 %    $    6,721,356      $    5,363,129      $   1,358,227     25.3 % 
 
 Total ARR (Annualized 
  recurring revenue):       $  20,918,954     $  17,423,330       $   3,495,624     20.1 %     $  20,918,954       $  17,423,330      $   3,495,624     20.1 % 
 
 Transaction Customers: 
 Corporate customers                1,028             1,093                (65)     -5.9 %             1,053               1,088               (35)     -3.2 % 
 Academic customers                   310               305                   5      1.6 %               320                 316                  4      1.3 % 
                         ----------------  ----------------  ------------------  ---------  ----------------  ------------------  -----------------  --------- 
 Total customers                    1,338             1,398                (60)     -4.3 %             1,373               1,404               (31)     -2.2 % 
 

Active Customer Accounts, Transactions and Annual Recurring Revenue

The Company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.

A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.

The Company defines annual recurring revenue ("ARR") as the value of contracted Platform subscription recurring revenue normalized to a one-year period. For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve.

Use of Non-GAAP Measure -- Adjusted EBITDA

Research Solutions' management evaluates and makes operating decisions using various financial metrics. In addition to the Company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the Company's operating results.

The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other (income) expense, foreign currency transaction (gain) loss, provision for income taxes, depreciation and amortization, stock-based compensation, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):

 
                                 Quarter Ended June 30,                                  Twelve Months Ended June 30, 
                     2025            2024           Change       % Change       2025            2024          Change       % Change 
                --------------  --------------  --------------  ---------  --------------  --------------  -------------  --------- 
 Net Income 
  (loss)        $    2,360,314  $  (2,821,227)   $   5,181,541     NM      $    1,265,553  $  (3,786,597)  $   5,052,150     NM 
 Add (deduct): 
 Other 
  (income) 
  expense          (1,163,557)       3,451,948     (4,615,505)     NM           1,152,847       2,903,983    (1,751,136)     NM 
 Foreign 
  currency 
  translation 
  loss (gain)         (83,322)           6,336        (89,658)     NM           (202,527)          21,395      (223,922)     NM 
 Provision for 
  income 
  taxes                  7,995          31,022        (23,027)   -74.2 %           82,811         113,071       (30,260)   -26.8 % 
 Depreciation 
  and 
  amortization         315,021         311,004           4,017    1.3 %         1,245,362         836,271        409,091   48.9 % 
 Stock-based 
  compensation         176,611         426,190       (249,579)   -58.6 %        1,723,561       2,155,461      (431,900)   -20.0 % 
                --------------  --------------  --------------  ---------  --------------  --------------  -------------  --------- 
 Adjusted 
  EBITDA        $    1,613,062  $    1,405,273  $      207,789   14.8 %    $    5,267,607  $    2,243,584  $   3,024,023   134.8 % 
 
 

About Research Solutions

Research Solutions, Inc. (NASDAQ: RSSS) is a vertical SaaS and AI Company that simplifies research workflow for academic institutions, life science companies, and research organizations worldwide. As one of the only publisher-independent marketplaces for scientific, technical, and medical $(STM)$ content, the Company uniquely combines AI-powered tools--including an intelligent research assistant and full-text search capabilities--with seamless access to both open access and paywalled research. The platform enables organizations to discover, access, manage and analyze scientific literature more efficiently, accelerating the pace of scientific discovery. For more information and details, please visit www.researchsolutions.com.

Important Cautions Regarding Forward-Looking Statements

Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates, " "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, creating long-term value for shareholders and the Company's prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission.

 
              Research Solutions, Inc. and Subsidiaries 
                Consolidated Balance Sheets (Unaudited) 
 
                                            June 30,       June 30, 
                                              2025           2024 
                                          -------------  ------------- 
                Assets 
Current assets: 
 Cash and cash equivalents                $  12,227,312  $   6,100,031 
 Accounts receivable, net of allowance 
  of $182,324 and $68,579, respectively       7,191,234      6,879,800 
 Prepaid expenses and other current 
  assets                                        580,257        643,553 
 Prepaid royalties                                  925      1,067,237 
                                           ------------   ------------ 
 Total current assets                        19,999,728     14,690,621 
 
Non-current assets: 
 Property and equipment, net of 
  accumulated depreciation of $964,883 
  and $922,558, respectively                     60,769         88,011 
 Intangible assets, net of accumulated 
  amortization of $2,736,773 
  and $1,535,310, respectively                9,686,241     10,764,261 
 Goodwill                                    16,372,979     16,315,888 
 Deposits and other assets                          957            981 
                                           ------------   ------------ 
Total assets                              $  46,120,674  $  41,859,762 
                                           ============   ============ 
 
 Liabilities and Stockholders' Equity 
Current liabilities: 
 Accounts payable and accrued expenses    $   7,443,757  $   8,843,612 
 Deferred revenue                            10,702,120      9,023,848 
 Contingent earnout liability, current 
 portion                                      7,363,152             -- 
                                           ------------   ------------ 
 Total current liabilities                   25,509,029     17,867,460 
 
Non-current liabilities: 
 Contingent earnout liability, long-term 
  portion                                     6,683,488     12,298,114 
                                           ------------   ------------ 
Total liabilities                            32,192,517     30,165,574 
                                           ------------   ------------ 
 
Commitments and contingencies 
 
Stockholders' equity: 
 Preferred stock; $0.001 par value; 
 20,000,000 shares authorized; no 
 shares issued and outstanding                       --             -- 
 Common stock; $0.001 par value; 
  100,000,000 shares authorized; 
  32,479,993 and 32,295,373 shares 
  issued and outstanding, respectively           32,480         32,295 
 Additional paid-in capital                  39,059,557     38,089,958 
 Accumulated deficit                       (25,043,693)   (26,309,246) 
 Accumulated other comprehensive loss         (120,187)      (118,819) 
                                           ------------   ------------ 
 Total stockholders' equity                  13,928,157     11,694,188 
                                           ------------   ------------ 
Total liabilities and stockholders' 
 equity                                   $  46,120,674  $  41,859,762 
                                           ============   ============ 
 
 
 Research Solutions, Inc. and Subsidiaries Consolidated Statements of 
     Operations and Other Comprehensive Income (Loss) (Unaudited) 
 
                                                   Years Ended 
                                                     June 30, 
                                            -------------------------- 
                                                2025          2024 
                                            ------------  ------------ 
 
Revenue: 
 Platforms                                  $ 18,955,695  $ 13,956,517 
 Transactions                                 30,102,286    30,667,382 
                                             -----------   ----------- 
 Total revenue                                49,057,981    44,623,899 
                                             -----------   ----------- 
 
Cost of revenue: 
 Platforms                                     2,371,540     2,067,203 
 Transactions                                 22,490,490    22,916,530 
                                             -----------   ----------- 
 Total cost of revenue                        24,862,030    24,983,733 
                                             -----------   ----------- 
Gross profit                                  24,195,951    19,640,166 
                                             -----------   ----------- 
 
Operating expenses: 
 Selling, general and administrative          20,449,378    19,573,438 
 Depreciation and amortization                 1,245,362       836,271 
                                             -----------   ----------- 
 Total operating expenses                     21,694,740    20,409,709 
                                             -----------   ----------- 
 
Income (loss) from operations                  2,501,211     (769,543) 
 
 Other income                                    595,679       333,088 
 Change in fair value of contingent 
  earnout liability                          (1,748,526)   (3,237,071) 
                                             -----------   ----------- 
 
Income (loss) before provision for income 
 taxes                                         1,348,364   (3,673,526) 
Provision for income taxes                      (82,811)     (113,071) 
                                             -----------   ----------- 
 
Net income (loss)                              1,265,553   (3,786,597) 
 
Other comprehensive income (loss): 
 Foreign currency translation                    (1,368)         (595) 
                                             -----------   ----------- 
Comprehensive income (loss)                 $  1,264,185  $(3,787,192) 
                                             ===========   =========== 
 
Basic income (loss) per common share: 
 Net income (loss) per share                $       0.04  $     (0.13) 
 Weighted average common shares 
  outstanding                                 30,681,187    28,863,949 
 
Diluted income (loss) per common share: 
 Net income (loss) per share                $       0.04  $     (0.13) 
 Weighted average common shares 
  outstanding                                 31,503,972    28,863,949 
 
 
              Research Solutions, Inc. and Subsidiaries 
                 Consolidated Statements of Cash Flows 
                              (Unaudited) 
 
                                                   Years Ended 
                                                    June 30, 
                                           --------------------------- 
                                               2025          2024 
                                           ------------  ------------- 
 
Cash flow from operating activities: 
 Net income (loss)                         $  1,265,553  $ (3,786,597) 
 Adjustment to reconcile net income 
 (loss) to net cash provided by 
 operating activities: 
 Depreciation and amortization                1,245,362        836,271 
 Stock options expense                          205,457        140,150 
 Restricted common stock expense              1,518,104      1,994,362 
 Modification cost of accelerated vesting 
  of restricted common stock                         --         20,949 
 Adjustment to contingent earnout 
  liability                                   1,748,526      3,237,071 
 Changes in operating assets and 
 liabilities: 
   Accounts receivable                        (341,434)      (344,020) 
   Prepaid expenses and other current 
    assets                                       63,296      (164,579) 
   Prepaid royalties                          1,066,312        135,441 
   Accounts payable and accrued expenses    (1,426,282)        560,027 
   Deferred revenue                           1,678,272        921,879 
                                            -----------   ------------ 
     Net cash provided by operating 
      activities                              7,023,166      3,550,954 
                                            -----------   ------------ 
 
Cash flow from investing activities: 
 Purchase of property and equipment            (19,261)       (71,510) 
 Payment for acquisition of Resolute, net 
  of cash acquired                                   --    (2,718,253) 
 Payment for acquisition of Scite, net of 
  cash acquired                                      --    (7,305,493) 
                                            -----------   ------------ 
     Net cash used in investing 
      activities                               (19,261)   (10,095,256) 
                                            -----------   ------------ 
 
Cash flow from financing activities: 
 Proceeds from the exercise of stock 
 options                                        180,800             -- 
 Common stock repurchase                      (934,577)      (554,202) 
 Payment of contingent acquisition 
  consideration                               (124,107)      (351,649) 
                                            -----------   ------------ 
     Net cash used in financing 
      activities                              (877,884)      (905,851) 
                                            -----------   ------------ 
 
Effect of exchange rate changes                   1,260          4,851 
                                            -----------   ------------ 
Net increase (decrease) in cash and cash 
 equivalents                                  6,127,281    (7,445,302) 
Cash and cash equivalents, beginning of 
 period                                       6,100,031     13,545,333 
                                            -----------   ------------ 
Cash and cash equivalents, end of period   $ 12,227,312  $   6,100,031 
                                            ===========   ============ 
 
Supplemental disclosures of cash flow 
information: 
 Cash paid for income taxes                $     82,811  $     113,071 
                                            ===========   ============ 
 
Non-cash investing and financing 
activities: 
 Contingent consideration accrual on 
  asset acquisition                        $     31,359  $      32,022 
                                            ===========   ============ 
 

View original content to download multimedia:https://www.prnewswire.com/news-releases/research-solutions-reports-fourth-quarter-and-fiscal-year-2025-results-302560891.html

SOURCE Research Solutions, Inc.

 

(END) Dow Jones Newswires

September 18, 2025 16:05 ET (20:05 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10